Soyoung “Sara” Park,


Hematologic Oncologist

Soyoung Park

Each and every day, I strive to provide compassionate care for my patients, treating them as if they were part of my family.

City of Hope Phoenix
14200 West Celebrate Life Way
Goodyear, AZ 85338
Hematologic Oncology
Medical school:

Tulane University School of Medicine, New Orleans, LA


Internal Medicine - University of Arizona, Tucson, AZ


Hematology/Oncology - University of Arizona, Tucson, AZ


Medical Oncology, Hematology and Internal Medicine - American Board of Internal Medicine

About Me

Dr. Soyoung “Sara” Park joined City of Hope in Phoenix, Arizona, in May 2021. She is an experienced hematologic oncologist who is board certified in internal medicine, medical oncology and hematology. Dr. Park has a special focus on patients with hematologic cancers.

She believes that patients benefit from the whole-person care offered at City of Hope, which not only treats cancer but helps manage symptoms and side effects.

“Working together with other doctors and supportive care clinicians, all under one roof, provides seamless care for our patients,” says Dr. Park. “I form trusted relationships with my patients, so they feel more secure, comfortable and confident throughout their treatment journey.”

Dr. Park completed a Bachelor of Science degree from the University of Texas in Austin, Texas. She earned a medical degree from Tulane University School of Medicine in New Orleans, Louisiana. Dr. Park completed a residency in internal medicine and a fellowship in hematology and oncology from the University of Arizona in Tucson, Arizona. She is a member of several professional organizations including the American Society of Hematology and American Society of Clinical Oncology.

Dr. Park likes spending time with her family and friends, including her husband and son. She also enjoys traveling, reading, watching home renovation shows and shopping.
Patient ratings
Star ratings and comments are only available for medical, radiation and gynecologic oncologists. Gynecologic surgical offerings are not included at this time due to a different survey tool required to evaluate these services. CTCA uses a validated Press Ganey® survey, which captures patient experience feedback for the primary oncology services of chemotherapy and radiation therapy at our comprehensive care and research centers. Following industry best practice, star ratings and comments are only published for physicians with a minimum of 30 completed patient surveys.